Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Must have a total score of 8 or greater on the O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) and a score of \> 0 on each of the 4 questions on the ICSI~* must have experienced bladder pain, urinary urgency and urinary frequency, each not related to a urinary tract infection, for at least 6 months prior to entry into the study~* must have averaged \>= 10 voids per day (\>=30 voids over 3 consecutive days) and averaged \>= 1 void at night~* urine culture showing no evidence of urinary tract infection~* urine cytology showing no evidence of neoplastic cells~Exclusion Criteria:~* Scheduled for or use of intravesical therapy (eg, bladder distention, dimethyl sulfoxide) during or within 4 weeks prior to the study~* patients who have had cytoscopic evaluation within 4 weeks prior to the study~* patients who are currently (within last month) receiving other medications that may affect symptoms of interstitial cystitis (ie, antidepressants, antihistamines, antispasmodics, anticholinergics)~* patients who are chronic users of Schedule II narcotics or who are using any scheduled narcotics at the time of study entry~* patients taking coumadin, anticoagulants, heparin, or thrombolytic agents such as tissue plasminogen activator and streptokinase

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pentosan polysulfate sodium 100 mg once a day (Type: EXPERIMENTAL): One 100 mg pentosan polysulfate sodium capsule in the morning and 1 matching placebo capsule in the afternoon and evening for 24 weeks
- Pentosan polysulfate sodium 100 mg three times a day (Type: EXPERIMENTAL): One 100 mg pentosan polysulfate sodium capsule 3 times a day (morning afternoon and evening) for 24 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Placebo One placebo capsule 3 times a day (morning afternoon and evening) for 24 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).